https://stock.noler.com/us/stock/concert-pharmaceuticals-inc https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/accounts-payable-and-accrued-liabilities-noncurrent https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/accounts-receivable https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/accrued-income-taxes https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/accrued-income-taxes-current https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/accrued-liabilities-and-other-liabilities https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/accrued-rent-current-and-noncurrent https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/additional-paid-in-capital https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/amortization-of-lease-incentives https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/aoci https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/assets-fair-value-disclosure https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/available-for-sale-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/available-for-sale-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/available-for-sale-amortized-cost https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/available-for-sale-current https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/available-for-sale-debt-current https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/available-for-sale-debt-realized-gain https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/available-for-sale-debt-realized-loss https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/available-for-sale-debt-unrealized-loss-position-loss https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/available-for-sale-gross-realized-gain-loss-excluding-other-than-temporary-impairments https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/available-for-sale-securities https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/basic-shares https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/buybacks-share-repurchases https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights-1 https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/common-stock-no-par-value https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/comprehensive-income https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/contract-liability https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/contract-with-customer-asset-net-current https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/contract-with-customer-liability-noncurrent https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/convertible-preferred-stock-shares-issued-upon-conversion https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/cumulative-earnings-deficit https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/debt-and-equity-securities-gain-loss https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/debt-interest-rate https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/debt-issued https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/debt-repaid https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/deferred-costs-current https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/deferred-offering-costs https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/deferred-rent-credit-current https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/deferred-revenue https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/deferred-revenue-2 https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/deferred-revenue-recognized https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/deferred-revenue-revenue-recognized https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards-not-subject-to-expiration https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/deferred-tax-assets-tax-credit-carryforwards-alternative-minimum-tax https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/deferred-tax-expense-from-stock-options-exercised https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/defined-contribution-plan-employer-matching-contribution-percent https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/defined-contribution-plan-employer-matching-contribution-percent-of-match https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/diluted-shares https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/dilutive-shares https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/effective-tax-rate https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/eps https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/eps-basic https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/equity-securities-fv-ni-realized-gain https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/equity-securities-fv-ni-realized-loss https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/equity-securities-fv-ni-unrealized-gain-loss https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/excess-tax-benefit-from-share-based-compensation-financing-activities https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/federal-income-tax-expense-benefit https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/gain-loss-on-sale-of-securities-net https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/gain-loss-on-sales-of-assets-and-asset-impairment-charges https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/impairment-of-investments https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/incentive-from-lessor https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/incentive-to-lessee https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/income-loss-attributable-to-parent https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/income-tax-receivable https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/income-taxes-paid https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/income-taxes-receivable https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/increase-decrease-in-accrued-interest-receivable-net https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/increase-decrease-in-contract-with-customer-asset https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/increase-decrease-in-deferred-charges https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/increase-decrease-in-deferred-liabilities https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/increase-decrease-in-income-taxes-receivable https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/insider-transactions-preferred https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/interest-expense-on-debt https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/interest-paid https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/interest-paid-net https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/interest-payable-current https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/interest-receivable https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/interest-receivable-current https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/investment-income-dividend https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/investments-and-cash https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/land-subject-to-ground-leases https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/lease-and-rental-expense https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/lease-incentive-payable-current https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/leasehold-improvements-gross https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/legal-fees https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/lessee-operating-lease-discount-rate https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/level-3-liability-gain-loss-included-in-earnings https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/level-3-liability-purchases-sales-issuances-settlements https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/liabilities-assumed https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/license-and-services-revenue https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/line-of-credit-facility-interest-rate https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/loans-payable-current https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/long-term-loans-payable https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/marketable-securities-current https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/marketable-securities-equity-securities-current https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/marketable-securities-unrealized-gain-loss https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/maturities-of-available-for-sale-securities https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/number-of-operating-segments https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/number-of-reportable-segments https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/oci-net-of-tax https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/oci-unrealized-holding-gain-loss-on-securities-arising-tax https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/operating-lease-assets https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/operating-lease-expense https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/operating-lease-liability https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/operating-lease-liability-current https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/operating-lease-payments https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/operating-lease-payments-due https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/other-current-liabilities https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/other-income https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/other-loans-payable-current https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/other-loans-payable-long-term https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/other-noncash-income https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/other-noncash-income-expense https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/other-noncurrent-assets https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/other-nonoperating-expense https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/other-nonoperating-income https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/other-sales-revenue-net https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/paid-in-capital-increase-in-carrying-amount-of-redeemable-preferred-stock https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/paid-in-capital-tax-effect-from-share-based-compensation https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/payments-for-proceeds-from-tenant-allowance https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/payments-to-acquire-investments https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/preferred-stock-value https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/pretax-income https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/proceeds-from-repayments-of-debt https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/professional-fees https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/repayments-of-other-long-term-debt https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/research-and-development-arrangement-contract-to-perform-for-others-compensation-earned https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/restricted-cash-noncurrent https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/revenue https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/revenue-from-contract-with-customer-including-assessed-tax https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/revenue-recognition-milestone-method-revenue-recognized https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/sale-of-stock-consideration-received-on-transaction https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/sale-of-stock-number-of-shares-issued-in-transaction https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/sales-revenue-net https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-award-fair-value-assumptions-weighted-average-volatility-rate https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-issued-shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-issued-shares-issued-value-restricted-stock-award-forfeitures https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-option-plan-expense https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/stock-split-ratio https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/tax-rate-reconciliation-other-reconciling-items-percent https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/taxes-payable-current https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/temporary-equity-accretion-to-redemption-value https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/temporary-equity-accretion-to-redemption-value-adjustment https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/temporary-equity-carrying-amount-including-portion-attributable-to-noncontrolling-interests https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/tenant-improvements https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/total-contract-liability https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/total-long-term-debt https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/undistributed-earnings-allocated-to-participating-securities https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/undistributed-earnings-loss-allocated-to-participating-securities-basic https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/undistributed-earnings-loss-allocated-to-participating-securities-diluted https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/utb-interest-on-income-taxes-accrued https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/warrant-down-round-feature-decrease-in-net-income-loss-to-common-shareholder-amount https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/warrant-down-round-feature-increase-decrease-in-equity-amount https://stock.noler.com/us/stock/concert-pharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted